The highlight of this study is the first to discover that LIQ can inhibit Ang II-induced cardiac hypertrophy by regulating the expression of ATE1 and thereby downregulating the ATE1/TAK1-JNK1/2 signaling pathway. The gene discussed is MAP3K7; the disease is cardiac hypertrophy.